Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryusuke Nambu

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Gastroenterology and Hepatology|October 13, 2020
Diagnostic accuracy of serum proteinase 3 antineutrophil cytoplasmic antibodies in children with ulcerative colitisTatsuki Mizuochi, Katsuhiro Arai, Takahiro Kudo, et al.
Journal of Clinical Immunology|March 11, 2021
Correction to: Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3Kay Tanita, Fumiaki Sakura, Ryusuke Nambu, et al.
Journal of Gastroenterology|January 26, 2020
Antibodies to Crohn's disease peptide 353 as a diagnostic marker for pediatric Crohn's disease: a prospective multicenter study in JapanTatsuki Mizuochi, Katsuhiro Arai, Takahiro Kudo, et al.
Journal of Clinical Immunology|January 27, 2021
Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3Kay Tanita, Fumiaki Sakura, Ryusuke Nambu, et al.
Intestinal Research|February 24, 2026
Characteristics of monogenic inflammatory bowel disease in very early-onset cases: a Japanese multicenter registry studyNatsuki Ito, Takahiro Kudo, Keisuke Jimbo, et al.
Scientific Reports|March 16, 2021
Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel diseaseLuca Bosa, Vritika Batura, Davide Colavito, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 28, 2025
Growth impairment in Japanese children with inflammatory bowel disease: A multicenter prospective cohort studyHirotaka Shimizu, Ryusuke Nambu, Nao Tachibana, et al.
Journal of Gastroenterology|January 3, 2026
Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease: a multi-center cohort studyRyusuke Nambu, Itaru Iwama, Ichiro Takeuchi, et al.
Journal of Gastroenterology|March 8, 2023
Clinical outcome of ulcerative colitis with severe onset in children: a multicenter prospective cohort studyRyusuke Nambu, Katsuhiro Arai, Takahiro Kudo, et al.
Journal of Gastroenterology|January 11, 2023
Expert consensus on vaccination in patients with inflammatory bowel disease in JapanTakashi Ishige, Toshiaki Shimizu, Kenji Watanabe, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Gastroenterology and Hepatology|October 13, 2020
Diagnostic accuracy of serum proteinase 3 antineutrophil cytoplasmic antibodies in children with ulcerative colitisTatsuki Mizuochi, Katsuhiro Arai, Takahiro Kudo, et al.
Journal of Clinical Immunology|March 11, 2021
Correction to: Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3Kay Tanita, Fumiaki Sakura, Ryusuke Nambu, et al.
Journal of Gastroenterology|January 26, 2020
Antibodies to Crohn's disease peptide 353 as a diagnostic marker for pediatric Crohn's disease: a prospective multicenter study in JapanTatsuki Mizuochi, Katsuhiro Arai, Takahiro Kudo, et al.
Journal of Clinical Immunology|January 27, 2021
Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3Kay Tanita, Fumiaki Sakura, Ryusuke Nambu, et al.
Intestinal Research|February 24, 2026
Characteristics of monogenic inflammatory bowel disease in very early-onset cases: a Japanese multicenter registry studyNatsuki Ito, Takahiro Kudo, Keisuke Jimbo, et al.
Scientific Reports|March 16, 2021
Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel diseaseLuca Bosa, Vritika Batura, Davide Colavito, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 28, 2025
Growth impairment in Japanese children with inflammatory bowel disease: A multicenter prospective cohort studyHirotaka Shimizu, Ryusuke Nambu, Nao Tachibana, et al.
Journal of Gastroenterology|January 3, 2026
Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease: a multi-center cohort studyRyusuke Nambu, Itaru Iwama, Ichiro Takeuchi, et al.
Journal of Gastroenterology|March 8, 2023
Clinical outcome of ulcerative colitis with severe onset in children: a multicenter prospective cohort studyRyusuke Nambu, Katsuhiro Arai, Takahiro Kudo, et al.
Journal of Gastroenterology|January 11, 2023
Expert consensus on vaccination in patients with inflammatory bowel disease in JapanTakashi Ishige, Toshiaki Shimizu, Kenji Watanabe, et al.
Pageof 6